Souid, Salim
Souid, Salim was paid $2.80M by Medicaid between Jan 2018 and Dec 2024, across 52 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 60% of everything it billed.
33Billing provider infoSOUID, SALIM
BROOKLYN, NY 11223
BROOKLYN, NY 11223
33aNPI1689869067assigned 09/10/2007
33bProvider typeStudent in an Organized Health Care Education/Training Program
28Total paid$2.80M
24GClaims76,857
24DCodes billed52
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Student in an Organized Health Care Education/Training Program providers in New York
Rank by total paid#4 of 2,013
Median peer was paid$4K
This provider vs. median757×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,608 | $351K | |
| 2019 | 7,720 | $327K | |
| 2020 | 5,957 | $313K | |
| 2021 | 5,325 | $329K | |
| 2022 | 15,069 | $471K | |
| 2023 | 25,085 | $636K | |
| 2024incomplete | 10,093 | $369K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 60% | 30,824 | 23,799 | $1.66M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 23% | 7,905 | 7,032 | $649K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 7.0% | 3,300 | 3,284 | $195K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.4% | 2,213 | 2,146 | $40K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.4% | 599 | 595 | $40K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.3% | 3,180 | 3,083 | $37K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 238 | 238 | $21K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 499 | 465 | $19K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 252 | 252 | $17K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 214 | 209 | $15K |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | <1% | 172 | 166 | $12K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 483 | 445 | $10K |
40 more codes
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 1,033 | $10K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 821 | $9K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 2,231 | $8K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 167 | $6K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 630 | $6K |
| 90461 | <1% | 370 | $5K | |
| 99401 | <1% | 201 | $4K | |
| 90658 | <1% | 261 | $4K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 492 | $4K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,854 | $3K |
| G0445 | High intensity behavioral counseling to prevent sexually transmitted infection; face-to-face, individual, includes: education, skills training and guidance on how to change sexual behavior; performed semi-annually, 30 minutes | <1% | 227 | $2K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 349 | $2K |
| 99441 | <1% | 91 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 333 | $2K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,030 | $1K |
| 94760 | <1% | 6,660 | $1K | |
| 99442 | <1% | 44 | $1K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 17 | $1K |
| 99383 | <1% | 14 | $1K | |
| 81002 | <1% | 647 | $1K | |
| 99384 | <1% | 13 | $1K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 31 | $850.00 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 2,232 | $442.14 |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 39 | $318.44 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 49 | $75.00 |
| 87400 | <1% | 296 | $68.41 | |
| 85018 | <1% | 372 | $60.29 | |
| 36410 | <1% | 44 | $28.78 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 49 | $25.00 |
| 99051 | <1% | 14 | $24.40 | |
| 99000 | <1% | 4,552 | $9.00 | |
| 99080 | 0% | 552 | $0.00 | |
| 90670 | 0% | 25 | $0.00 | |
| 90715 | 0% | 12 | $0.00 | |
| 90707 | 0% | 21 | $0.00 | |
| 90633 | 0% | 12 | $0.00 | |
| 87501 | 0% | 43 | $0.00 | |
| 90734 | 0% | 13 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 120 | $0.00 |
| 90716 | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.